238 related articles for article (PubMed ID: 31738422)
1. A Network Analysis of Epigenetic and Transcriptional Regulation in a Neurodevelopmental Rat Model of Schizophrenia With Implications for Translational Research.
Du Y; Li XS; Chen L; Chen GY; Cheng Y
Schizophr Bull; 2020 Apr; 46(3):612-622. PubMed ID: 31738422
[TBL] [Abstract][Full Text] [Related]
2. The methylazoxymethanol acetate rat model: molecular and epigenetic effect in the developing prefrontal cortex: An Editorial Highlight for 'Epigenetic mechanisms underlying NMDA receptor hypofunction in the prefrontal cortex of juvenile animals in the MAM model for schizophrenia' on page 320.
Zhu X; Gomes FV; Grace AA
J Neurochem; 2017 Nov; 143(3):264-267. PubMed ID: 28872674
[TBL] [Abstract][Full Text] [Related]
3. The methylazoxymethanol acetate (MAM-E17) rat model: molecular and functional effects in the hippocampus.
Hradetzky E; Sanderson TM; Tsang TM; Sherwood JL; Fitzjohn SM; Lakics V; Malik N; Schoeffmann S; O'Neill MJ; Cheng TM; Harris LW; Rahmoune H; Guest PC; Sher E; Collingridge GL; Holmes E; Tricklebank MD; Bahn S
Neuropsychopharmacology; 2012 Jan; 37(2):364-77. PubMed ID: 21956444
[TBL] [Abstract][Full Text] [Related]
4. Memory deficits with intact cognitive control in the methylazoxymethanol acetate (MAM) exposure model of neurodevelopmental insult.
O'Reilly KC; Perica MI; Fenton AA
Neurobiol Learn Mem; 2016 Oct; 134 Pt B(Pt B):294-303. PubMed ID: 27485950
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome Analysis and Epigenetics Regulation in the Hippocampus and the Prefrontal Cortex of VPA-Induced Rat Model.
Chen L; Fu Q; Du Y; Jiang ZY; Cheng Y
Mol Neurobiol; 2024 Jan; 61(1):167-174. PubMed ID: 37592184
[TBL] [Abstract][Full Text] [Related]
6. Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia.
Stark T; Ruda-Kucerova J; Iannotti FA; D'Addario C; Di Marco R; Pekarik V; Drazanova E; Piscitelli F; Bari M; Babinska Z; Giurdanella G; Di Bartolomeo M; Salomone S; Sulcova A; Maccarrone M; Wotjak CT; Starcuk Z; Drago F; Mechoulam R; Di Marzo V; Micale V
Neuropharmacology; 2019 Mar; 146():212-221. PubMed ID: 30496751
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in neuronal oscillatory activity and memory in the methylazoxymethanol acetate model of schizophrenia.
Albeely AM; Williams OOF; Blight CR; Thériault RK; Perreault ML
Schizophr Res; 2024 May; 267():451-461. PubMed ID: 38643726
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic mechanisms underlying NMDA receptor hypofunction in the prefrontal cortex of juvenile animals in the MAM model for schizophrenia.
Gulchina Y; Xu SJ; Snyder MA; Elefant F; Gao WJ
J Neurochem; 2017 Nov; 143(3):320-333. PubMed ID: 28628228
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities in behaviour, histology and prefrontal cortical gene expression profiles relevant to schizophrenia in embryonic day 17 MAM-Exposed C57BL/6 mice.
Huo C; Liu X; Zhao J; Zhao T; Huang H; Ye H
Neuropharmacology; 2018 Sep; 140():287-301. PubMed ID: 30056124
[TBL] [Abstract][Full Text] [Related]
10. Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia.
Penschuck S; Flagstad P; Didriksen M; Leist M; Michael-Titus AT
Eur J Neurosci; 2006 Jan; 23(1):279-84. PubMed ID: 16420437
[TBL] [Abstract][Full Text] [Related]
11. Prenatal MAM administration affects histone H3 methylation in postnatal life in the rat medial prefrontal cortex.
Maćkowiak M; Bator E; Latusz J; Mordalska P; Wędzony K
Eur Neuropsychopharmacol; 2014 Feb; 24(2):271-89. PubMed ID: 23932495
[TBL] [Abstract][Full Text] [Related]
12. Genetic regulatory subnetworks and key regulating genes in rat hippocampus perturbed by prenatal malnutrition: implications for major brain disorders.
Chen J; Zhao X; Cui L; He G; Wang X; Wang F; Duan S; He L; Li Q; Yu X; Zhang F; Xu M
Aging (Albany NY); 2020 May; 12(9):8434-8458. PubMed ID: 32392183
[TBL] [Abstract][Full Text] [Related]
13. Aberrant high frequency oscillations recorded in the rat nucleus accumbens in the methylazoxymethanol acetate neurodevelopmental model of schizophrenia.
Goda SA; Olszewski M; Piasecka J; Rejniak K; Whittington MA; Kasicki S; Hunt MJ
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Aug; 61():44-51. PubMed ID: 25862088
[TBL] [Abstract][Full Text] [Related]
14. Effect of estrous cycle on schizophrenia-like behaviors in MAM exposed rats.
Perez SM; Donegan JJ; Lodge DJ
Behav Brain Res; 2019 Apr; 362():258-265. PubMed ID: 30660776
[TBL] [Abstract][Full Text] [Related]
15. A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia.
Moore H; Jentsch JD; Ghajarnia M; Geyer MA; Grace AA
Biol Psychiatry; 2006 Aug; 60(3):253-64. PubMed ID: 16581031
[TBL] [Abstract][Full Text] [Related]
16. Structural abnormalities revealed by magnetic resonance imaging in rats prenatally exposed to methylazoxymethanol acetate parallel cerebral pathology in schizophrenia.
Chin CL; Curzon P; Schwartz AJ; O'Connor EM; Rueter LE; Fox GB; Day M; Basso AM
Synapse; 2011 May; 65(5):393-403. PubMed ID: 20803618
[TBL] [Abstract][Full Text] [Related]
17. Role of the prefrontal cortex in altered hippocampal-accumbens synaptic plasticity in a developmental animal model of schizophrenia.
Belujon P; Patton MH; Grace AA
Cereb Cortex; 2014 Apr; 24(4):968-77. PubMed ID: 23236209
[TBL] [Abstract][Full Text] [Related]
18. Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment.
Stark T; Di Bartolomeo M; Di Marco R; Drazanova E; Platania CBM; Iannotti FA; Ruda-Kucerova J; D'Addario C; Kratka L; Pekarik V; Piscitelli F; Babinska Z; Fedotova J; Giurdanella G; Salomone S; Sulcova A; Bucolo C; Wotjak CT; Starcuk Z; Drago F; Mechoulam R; Di Marzo V; Micale V
Biochem Pharmacol; 2020 Jul; 177():114004. PubMed ID: 32360362
[TBL] [Abstract][Full Text] [Related]
19. Prenatal treatment with methylazoxymethanol acetate as a neurodevelopmental disruption model of schizophrenia in mice.
Takahashi K; Nakagawasai O; Sakuma W; Nemoto W; Odaira T; Lin JR; Onogi H; Srivastava LK; Tan-No K
Neuropharmacology; 2019 May; 150():1-14. PubMed ID: 30831160
[TBL] [Abstract][Full Text] [Related]
20. The prenatal methylazoxymethanol acetate treatment: a neurodevelopmental animal model for schizophrenia?
Jongen-Rêlo AL; Leng A; Lüber M; Pothuizen HH; Weber L; Feldon J
Behav Brain Res; 2004 Mar; 149(2):159-81. PubMed ID: 15129780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
